Kenneth J. Slepicka
Founder & Director
Mr. Slepicka has more than twenty years experience in the financial industry, most notably as a director of several public companies as well as a senior consultant/advisor to several start-up initiatives including biotechnology and a pharmaceutical training company. Mr. Slepicka spent 15 years as a Portfolio and Risk Manager for global bank UBS, and was president of the bank's U.S. subsidiary, UBS Futures Inc. Prior to his senior positions at UBS, Mr. Slepicka was a derivative trader and risk manager for O'Connor and Associates. Mr. Slepicka then worked with a private equity group that invested in a medical device company and has an MBA from the JL Kellogg School of Management, Northwestern University.
Thomas Piccariello, PhD.
President and Director
Dr. Piccariello, 61, has experience in the fields of synthetic chemistry, metallurgy, electrochemistry, plant enzymology, chemical manufacturing and pharmacology. In addition to serving as the lead scientist for two pharmaceutical start-up companies (both of which are now publicly traded, Insmed and New River Pharmaceuticals), Dr. Piccariello founded and ran his own contract research and contract manufacturing companies, which he later sold. Dr. Piccariello has 23 patents and patent applications to his credit, 18 of which deal with novel drug delivery technologies. Dr. Piccariello has a B.S. in biology and a Ph.D. in chemistry from Virginia Polytechnic Institute and State University (Virginia Tech).
CEO & Chairman of the Board
John Tinkham, 56, is our general counsel and vice president of development. Mr. Tinkham was most recently assistant general counsel for Integra LifeSciences Holdings Corporation, where he was responsible for securities law, mergers and acquisitions and licensing and intellectual property matters. Prior to joining Integra, Mr. Tinkham was associated with Latham & Watkins. Mr. Tinkham holds a J.D. from Boalt Hall School of Law at the University of California, Berkeley and a B.A. from Northwestern University.
VP of Research and Development
Dr. Price has over 15 years of discovery and development experience in the pharmaceutical and biotechnology industries. Dr. Price has a B.S. in chemical engineering from Washington University and a Ph.D. in organic chemistry from Iowa State University.
He spent several years in the laboratory of Joseph Larner, MD, Ph.D., Emeritus Professor at the University of Virginia school of Medicine, studying metal coordination of small molecule insulin mimetics.
Scott Palmer, M.D.
Director and Chairman of Scientific Advisory Board
Dr. Scott Palmer, M.D., is a board certified physician in Internal Medicine. He is a graduate of the University of Michigan and Rush Medical College. Dr. Palmer did his internship, residency and chief residency at Presbyterian St. Luke's Hospital in Chicago, Illinois. Dr. Palmer has been selected as one of the "Top Doctors: Chicago Metro Area" by Castle Connolly Medical Ltd. and Consumer's Checkbook, as well as being selected "America's Top Physicians" by Consumer's Research Council of America, Washington, D.C.
Dr. Palmer is a member of the American Medical Association, American College of Physicians and the Chicago Society of Medical Medicine. Dr. Palmer is also the Medical Team Physician of the Chicago Bulls and the Chicago White Sox. In addition to chairing Synthonics Inc. Scientific Advisory Board, Dr. Palmer is a member of Synthonics Board of Directors. Dr. Palmer's interests are in pharmaceutical research, exploring the treatment of autism, cancer, neurodegenerative disorders and infections diseases. Synthonics Inc. has developed a novel drug delivery platform that could markedly improve the treatment of many of these diseases. Dr. Palmer is also a named inventor of Synthonics "Frequency Modulated Drug Delivery" patent, which combines any two compounds to a single metal ion.
Director and Chairman of Business Advisory Board
John Borling is a highly decorated, retired Air Force Major General. He served worldwide in high level command and staff positions. A fighter pilot, he graduated from the Air Force Academy, the National War College, executive education at Harvard - the Business School and the JFK School - and he was a White House Fellow.
During the Vietnam War, he was shot down by ground fire. Seriously injured, he was captured while trying to evade and spent over 6 ½ years as a POW in Hanoi. Currently, he occupies leadership positions in multiple civic and business organizations. He is the author of the nationally acclaimed book "Taps on the Walls."